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Summary
Objective: To identify differentially expressed genes between axially impacted and control articular cartilage taken from porcine patellae
maintained in organ culture for 14 days.
Methods: Porcine patellae were impacted perpendicular to the articular surface to create an impact injury. Intact patellae (control and
impacted) were maintained in culture for 14 days. Total RNA was then extracted from the articular cartilage beneath the impaction and
used to prepare two Serial Analysis of Gene Expression (SAGE) libraries. Approximately 42,500 SAGE long tags were sequenced from
the libraries. The expression of select genes was conﬁrmed by quantitative real-time PCR analysis.
Results: Thirty-nine SAGE tags were signiﬁcantly differentially expressed in the impacted and control libraries, representing 30 different
annotated pig genes. These genes represented gene products associated with matrix molecules, iron and phosphate transport, protein
biosynthesis, skeletal development, cell proliferation, lipid metabolism and the inﬂammatory response. Twenty-three of the 30 genes were
down-regulated in the impacted library and ﬁve were up-regulated in the impacted library. Quantitative real-time PCR follow-up of four genes
supported the results found with SAGE.
Conclusion: We have identiﬁed 30 putative genes differentially expressed in a porcine impact injury model and validated these ﬁndings for four
of these genes using real-time PCR. Results using this impact injury model have contributed further evidence that damaged chondrocytes may
de-differentiate into ﬁbroblast-like cells and proliferate in an attempt to repair themselves. Additional work is underway to study these genes in
further detail at earlier time points to provide a more complete story about the fate of chondrocytes in articular cartilage following an injury.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Abbreviations: ACTB beta actin, APOD apolipoprotein D, CAPNS1 calpain I light subunit, CATHB cathepsin B, CATHD cathepsin D,
CLU clusterin, COL1A1 collagen type I, alpha 1 chain, COL2A1 collagen type II, alpha 1 chain, COX8A cytochrome c oxidase subunit
8A, CXCL16 chemokine C-X-C motif ligand 16, FMOD ﬁbromodulin, FTH1 ferritin heavy chain 1, FTL ferritin light subunit, GAPDH
glyceraldehyde-3-phosphate dehydrogenase, GO Gene Ontology, GP38K 38 kDa heparin-binding glycoprotein, MDK midkine, MMP matrix
metalloproteinase, NACA nascent polypeptide-associated complex, alpha subunit, NGAL neutrophil gelatinase-associated lipocalin, PMMA
polymethyl methacrylate, RPL11 60S ribosomal protein L11, RPL13a 60S ribosomal protein L13a, RPL23 60S ribosomal protein L23,
RPLP2 60S ribosomal protein P2, RPS14 40S ribosomal protein S14, RPS18 40S ribosomal protein S18, RPS20 40S ribosomal protein
S20, RPS23 40S ribosomal protein S23, RPS27 40S ribosomal protein S27, S100A11 S100 calcium binding protein A11, also named
calgizzarin, SAA2 serum amyloid A2, SAGE Serial Analysis of Gene Expression, SERPINA serine protease inhibitor, SPARC secreted protein
acidic and rich in cysteine, SRPSOX scavenger receptor for phosphatidylserine and oxidized low density lipoprotein, TIMP tissue inhibitors of
matrix metalloproteinases, TMED2 transmembrane emp24 domain trafﬁcking protein 2.Introduction
Degenerative joint diseases such as osteoarthritis (OA)
affect more than 20 million people in the USA alone and,
with the continued aging of the population, these numbers
will continue to rise1,2. The ability of articular joints to
perform their function of allowing smooth, painless motion
and the transmission of joint forces is highly dependent
on the condition of the thin layer of cartilage tissue covering*Address correspondence and reprint requests to: Dr Melissa
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936the joint’s bony surface. In turn, the ability of cartilage to
perform its function depends on the tissue’s integrity and
the interactions between the matrix and chondrocytes.
While the causes of joint degenerative diseases such as
OA are multifactorial and involve all the joint tissue, the car-
tilage is particularly vulnerable because it has a very limited
ability to affect healing, making any recovery difﬁcult. Thus,
understanding what happens to the chondrocytes and their
role in the degenerative process is critical to understanding
the progression of the disease and determining the tissue’s
potential for healing and repair.
While we know a great deal about the end stages of OA
because it is at this stage that treatment is sought, the
mechanisms that initiate the degenerative process are
poorly understood. Since joint injuries are known to be a pre-
disposing factor for the development of later cartilage
degeneration and OA, injury models have been used
937Osteoarthritis and Cartilage Vol. 16, No. 8extensively to aid in the study of cartilage degeneration and
the development of OA3e7.
Although the pathology and chronology of the disease
process are not yet fully understood, we know several
different degenerative events take place involving the
chondrocytes and extracellular matrix as a result of an in-
jury4,8e10. There is an initial damage to the cartilage matrix,
including cartilage cracks11e17, disruption of the collagen
network18, and loss of proteoglycan14,15,17. Chondrocyte
death, both necrotic and apoptotic, has also been reported
in many studies19e24. Chondrocytes may attempt to repair
the damage by increasing production of degenerative
enzymes [matrix metalloproteinases (MMPs), etc.] to begin
removing damaged tissue and increasing production of new
matrix products to start the rebuilding process. Evidence
suggests that cell cloning takes place25,26 which may be
an effort to replace dead cells or bring in additional cells
to aid in the repair process. Chondrocytes may also revert
to more ﬁbroblast-like phenotype27,28. Many of the changes
that we see in the tissue are likely attempts at repair;
however, we know these attempts are often unsuccessful
because many joints go on to develop severely debilitating
degeneration.
Functional genomics approaches have become important
tools that can be used to provide insight into the genes
expressed in normal and osteoarthritic human cartilage.
Many studies have provided data for a transcriptome map
of cartilage, estimated to contain 13,000e16,000 genes29.
These studies have provided the sequence information
needed for development of microarrays that have been
used to study the disease process. The ﬁrst publication
using cDNA microarrays speciﬁc to cartilage showed that
MMP3 was expressed in normal cartilage and early OA,
but down-regulated in late OA30. Since that ﬁrst report, ad-
ditional studies using functional genomics approaches have
been conducted with samples taken from a variety of animal
models. While results from these studies have been very
useful in expanding our understanding of the disease pro-
cess, some of the results have provided conﬂicting data
for many of the genes thought to be involved in joint degen-
eration. For example, MMP3 transcript levels have been
found to be both down-regulated30,31 and up-regulated32,33.
Similarly other genes, such as aggrecan and collagen type
II, were up-regulated in some studies and down-regulated
or unchanged in others30,31,33. Genomics studies have
also identiﬁed other differentially expressed genes that
had never previously been reported to be involved in
OA32. While some of the variability seen in these studies
may be explained by the use of different models
[differences in cartilage age (mature vs immature), joints
used or joint locations, method of injury, or the time point
in the disease process], this variability also demonstrates
our lack of understanding of the true pathophysiology of
this condition.
Knowing the early changes that occur in chondrocyte
gene expression following an impact injury and how these
changes relate to the observed tissue damage will provide
insights into the progression of early degenerative changes
in the cartilage tissue. Are chondrocytes capable of
orchestrating a successful repair or are their efforts doomed
to failure? If we can gain a better understanding of the early
degenerative changes that precede the full blown disease,
we will be better able to treat the disease and prevent the
debilitating changes that occur further down the road.
Our primary goal in this study is to examine the transcript
proﬁle of chondrocytes following an injury and compare it to
the transcript proﬁle of chondrocytes from normal tissue inorder to elucidate the molecular pathways involved in carti-
lage degeneration. Two Serial Analysis of Gene Expression
(SAGE) libraries34 were constructed from axially impacted
and non-impacted control porcine cartilage maintained for
14 days in organ culture to identify differentially expressed
genes that may give us clues about the early changes in
chondrocytes that lead to later OA.Materials and methodsTISSUE COLLECTION AND PROCESSINGPorcine knee joints from 10 animals were obtained from a local slaughter-
house. The tissue was from retired sows of unknown age with a minimum
weight of approximately 180 kg. Only patellae with visually healthy cartilage
(no ﬁbrillation or other signs of degeneration) were used. Patellae were
removed sterilely from the knee joints within 3 h of slaughter. Once removed
from the joint capsule, and throughout the procedure, the patellae were kept
immersed in phosphate-buffered saline (PBS) with antibiotics to prevent tis-
sue drying.
To create a secure holder for the patellae while they were impacted, the
bony non-articular surface was pressed into partially set polymethyl methac-
rylate (PMMA) (Osteobond, Zimmer,Warsaw, IN) in a spherically bottomed
mold creating an individual impression. Patellae were removed immediately
to prevent any heat related damage as the PMMA cured. For impaction, the
patellae were replaced in the PMMAmolds and clamped in an xey positioning
jig attached to the base of a servo-hydraulic load frame (MTS Mini Bionix 858,
MTS Systems Inc., Minneapolis, MN). The xey positioning jig and the
rounded PMMA base allowed the patella to be rotated and translated so
both the medial and lateral facets could be aligned perpendicular to the load-
ing direction, insuring a contact surface that was as ﬂat as possible and pre-
venting any unintended motions during impactions (Fig. 1).
Axial impactions were carried out at a loading rate of 25 mm/s to a load
level of 2000 N using a protocol we previously developed35,36. Contact
was made using a 10-mm long, 10-mm diameter, stainless steel cylindrical
impactor oriented with the cylinder’s long axis perpendicular to the loading
direction and running along the medialelateral axis of the patella. A curved
proﬁle for the impactor was chosen so that there would be no edges that
could induce a tear in the cartilage during the impaction. If any cracks devel-
oped in the tissue, we wanted to be sure that they resulted from the stresses
or strains generated by the impaction and not the geometry of the impactor or
stress concentrations generated at an edge. Each patella was impacted at
the same load level in the center of each of the two facets. Previous work
in our lab using Fuji ﬁlm has shown that this loading results in peak surface
stresses on the order of 40e50 MPa. Tissue marking dye (Polysciences,
Inc., Warrington, PA), which remains on the tissue surface through the
culture period and subsequent tissue processing, was used to create marks
on the cartilage surface at each end of the impactor to act as reference
markers for identiﬁcation of the center of impaction when patellae were
removed from culture.
Following impactions, intact patellae were washed three times in PBS with
antibiotics and placed in deep Pyrex culture dishes allowing their complete
immersion in culture media: Delbecco’s MEM/Ham’s F12 with 10% fetal
calf serum, ascorbic acid (25 mg/mL), and antibiotics (penicillin 100 units/
mL, streptomycin 100 mg/mL, and amphotericin B 25 mg/mL) (Invitrogen
Corporation, Carlsbad, CA). Patellae were maintained at 37C in a humidiﬁed
incubator with 5% CO2 for 14 days. Media was changed daily and culture
dishes constantly agitated to ensure the media was well oxygenated and
evenly mixed.
After the patellae were removed from culture, full thickness cartilage
tissue slices directly under the area of impaction were excised from each
facet and ﬂash frozen in liquid nitrogen. Tissue from the non-impacted
control patellae was harvested in the same manner. Tissue slices from the
non-impacted control patellae were approximately 10-mm long and 10-mm
wide. Slices only 5-mm wide were taken from the impacted facets to ensure
that only tissue directly below the area of impaction was collected.RNA ISOLATIONFor SAGE library construction, total RNA was isolated from articular chon-
drocytes using the Biochain RNA isolation kit (Hayward, CA) following the
manufacturer’s protocol. Eight full thickness impacted cartilage strips were
pooled to obtain 500 mg of starting material for the impacted library and three
full thickness strips were pooled for the control library. Tissue was ground to
a ﬁne powder in liquid nitrogen with a mortar and pestle and homogenized
with a Biospec Tissue-Tearor homogenizer (Biospec Products, Inc., Bartles-
ville, OK). RNA was quantitated on a Nanodrop-1000 spectrophotometer
(NanoDrop Technologies, Wilmington, DE). The impacted and non-impacted
cartilage samples yielded 24 mg and 15 mg of total RNAs, respectively. RNA
Fig. 1. Patellae impaction setup. (A). Hydraulic load frame with impactor. (B). Patellae potted in spherically bottomed PMMA mold. (C). Holder
and xey positioning jig. (D). Close up of patellae impaction.
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RNA.
Four impacted strips and ﬁve control strips were used for quantitative real-
time PCR validation. Individual strips were ground to a powder with a mortar
and pestle and homogenized using a Tissue-Tearor homogenizer in 15 mL
TriReagent solution (Molecular Research Center, Inc., Cincinnati, OH) for
2 min. Glycogen (20 mg) (Sigma-Aldrich, St. Louis, MO) and 1 mL chloroform
were added to samples which were then incubated for 15 min at room
temperature. Samples were centrifuged at 15,000 g for 10 min and the
aqueous layer transferred to a new tube. A second phenol/chloroform extrac-
tion was performed and the RNA was precipitated with 2.5 mL isopropanol.
After an 8-min centrifugation at 12,000 g, the RNA pellet was washed
with 5 mL 75% ethanol and dissolved in diethyl pyrocarbonate (DEPC)
water. RNA quantity and purity were examined with a NanoDrop-1000 spec-
trophotometer and 2% agarose gel electrophoresis.SAGE LIBRARY CONSTRUCTION AND SEQUENCINGTotal RNA was bound to oligo-dT beads and SAGE libraries were gener-
ated with Invitrogen’s I-SAGE Long kit (Carlsbad, CA) following the manufac-
turer’s protocol. Brieﬂy, in the SAGE technique, a 17-bp region or ‘‘tag’’ is
captured from each expressed transcript. These tags are concatemerized,
cloned, and sequenced to determine a small region of each represented
transcript. Concatemerized tags were cloned and grown on low salt Luria
broth (LB) media. Inserts were veriﬁed by colony PCR and plasmid DNA
was isolated using a standard alkaline lysis miniprep procedure. Plasmid
DNAwasRNase-treated using Ambion’s RNaseCocktail (Foster City, CA) so-
lution following the manufacturer’s protocol. Plasmid DNA was quantitated
with a Nanodrop-1000 spectrophotometer and visualized on a 1.5% agarose
gel. Clones with inserts ranging from 500 bp to 1000 bp were sequenced on
a 50-cm array using Applied Biosystems (Foster City, CA) v3.1 Big Dye Ter-
minator Cycle Sequencing kit on an ABI3100 Genetic Analyzer. Sequence
quality was analyzed using Applied Biosystems Sequence Analysis software
v5.1.PROCESSING AND ANALYSIS OF SAGE TAGSSAGE tags were extracted from sequence data using the SAGE 2000
v4.5 software34. Microsoft Access was used to generate a complete list ofSAGE tags, number of times each tag was found in the two libraries, and
the gene identiﬁcation, if known. Gene identiﬁcations were matched to
SAGE tags by downloading the NCBI Sus scrofa NlaIII reliable tag-to-gene
mappings ﬁle. The tags were also compared to the pig non-redundant
database and the pig SAGE14 database (http://compbio.dfci.harvard.edu/
tgi/) using basic local alignment search tool (BLAST) for gene identiﬁcation
conﬁrmation.
The Audic and Claverie method37 was used to statistically compare the
number of unique tags between libraries using the Identiﬁcation of Differen-
tially Expressed Genes Test Statistics version 6 (IDEG6) software38 (http:
//telethon.bio.unipd.it/bioinfo/IDEG6_form/). IDEG6 is a web tool designed
to identify differentially expressed genes in multiple tag experiments, allow-
ing the user to select from different test statistics39. Audic and Claverie37
developed a test for pairwise comparisons of expression data acquired
speciﬁcally from tag sampling experiments such as SAGE. P values from
the Audic and Claverie method were adjusted to account for multiple testing
by use of the False Discovery Rate (FDR)40. An FDR-adjusted
P value< 0.05 was considered a statistically signiﬁcant result.REAL-TIME PCR VALIDATIONThe High Capacity cDNA Reverse Transcription Kit (Applied Biosystems,
Inc., Foster City, CA) was used to synthesize cDNA from RNA following the
manufacturer’s instructions. Four impacted and ﬁve control tissue samples
were used for real-time PCR validation. Real-time primers were designed
with Beacon Designer software (Premier Biosoft Intl., Palo Alto, CA;
Table I). Primers were designed to be compatible with SYBR Green I by
avoiding regions of cross-homology between the genes of interest and the
Sus scrofa RNA Reference Sequence database. The M-fold program (Pre-
mier Biosoft Intl., Palo Alto, CA) predicted template secondary structures
that were avoided when designing primers. Primers were designed from por-
cine gene sequences when available. When the porcine sequence was un-
available, primers were designed from conserved regions among human,
bovine, and canine sequences. Primers were designed to amplify across
at least one predicted exoneintron boundary. Exoneintron boundaries
were predicted by comparing porcine cDNA sequence to the March 2006 as-
sembly of the human genome using the UCSC BLAT program (http://
genome.ucsc.edu/cgi-bin/hgBlat). Human beta actin (ACTB) primers were
used to design porcine ACTB primers by aligning the human primers to
the porcine ACTB gene. Where the human primer and porcine gene
Table I
Quantitative real-time PCR primers
Gene Primer sequences Annealing temperature ((C) Amplicon size (bp)
ACTB Forward: 50-TCGCCGACAGGATGCAGAAGGA-30 52 129
Reverse: 50-AGGTGGACAGCGAGGCCAGGAT-30
MMP3 Forward: 50-GATGTTGGTTACTTCAGCAC-30 59 197
Reverse: 50-ATCATTATGTCAGCCTCTCC-30
FTH1 Forward: 50-TGATGTGGCTTTGAAGAAC-30 59 275
Reverse: 50-GCGTCTCAATGAAGTCAC-30
RPS23 Forward: 50-GCCATCAGGAAGTGTGTCAG-30 59 129
Reverse: 50-GCGACCAAATCCAGCAACC-30
GP38K Forward: 50-TGACGCTCTATGACACAC-30 56 194
Reverse: 50-GGCTAGGTCCAGTCCATC-30
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Human ACTB (RTPrimerDB-ID: 2217) primer sequences are available in
the public RTPrimerDB database (http://medgen.UGent.be/rtprimerdb/)41.
Quantitative real-time PCR was performed in a Bio-Rad iCycler IQ
thermocycler (Hercules, CA) with 1X Applied Biosystems Power SYBR
Green PCR Master Mix (Foster City, CA), 200 nM forward and reverse
primers, 10 nM ﬂuorescein, and 1 mL cDNA. Fluorescein was added as a ref-
erence dye. Reactions were heated for 10 min at 95C, followed by 50 cycles
of 95C for 30 s, 51e60C for 30 s, and 72C for 30 s. A 72C extension step
was added after completion of the cycles. Triplicate reactions were
performed and cycle threshold (CT) values were averaged for each sample.
Melting curves for each PCR reaction were generated to assess speciﬁc-
ity of the reaction. One amplicon generated by each primer pair was
sequenced to conﬁrm the identity of the PCR product using the ABI Big
Dye Terminator Version 1.1 Sequencing Kit and an ABI3100 Genetic
Analyzer (Foster City, CA).
Standard curves were generated for each primer pair by amplifying serial
dilutions of pooled cDNA in the same plate as samples. To create the pool,
RNA from each patella was isolated and cDNA synthesized using the
protocols described above. Equal amounts of cDNA from each tissue were
subsequently pooled. Five 1:3 serial dilutions were prepared and dilutions
were ampliﬁed in triplicate to estimate PCR ampliﬁcation efﬁciency using
the iCycler iQ Real-Time PCR Detection System Software v3.1 (Bio-Rad,
Hercules, CA). Efﬁciencies were used when estimating gene expression
ratios and statistical signiﬁcance between impacted and control tissues.
Relative Expression Software Tool (REST) v1.9.12 was used to test for
signiﬁcance and quantify expression ratios between impacted and control
sample CT values
42,43. This software tool used the comparative quantiﬁca-
tion method to compare gene expression between samples. Sample CT
values were normalized with CT values from ACTB. ACTB was judged to
be a good housekeeping gene because ACTB tags were not differentially
expressed between impacted and control SAGE libraries. REST used the
mean CT values for the treatment and control groups and the PCR
ampliﬁcation efﬁciencies to estimate gene expression ratios between the
two groups42. Statistical signiﬁcance was tested by a randomization test
with 50,000 permutations, and bootstrapping was used to estimate 95%Table I
Abundant tags found in impac
Transcript identiﬁcation No. tags in
impacted
No. tags
in control
SAA2 1781 1838
GP38K 544 1291
NEU-related lipocalin (NACA) 313 683
CLU 286 140
Ribosomal protein S15 (RPS15) 247 158
FMOD 176 295
Ribosomal protein L10 (RPL10) 163 174
Ribosomal protein L28 (RPL28) 162 127
Ribosomal protein L13 (RPL13) 161 142
CATHD 149 129
FTL 143 168
SPARC 128 139conﬁdence intervals (CIs)43. A P value less than 0.05 was considered
a statistically signiﬁcant result.ResultsSAGE LIBRARY RESULTSA total of 42,530 SAGE long tags were obtained and
sequenced from the axially impacted and control SAGE
libraries (21,030 and 21,500 tags from each library, respec-
tively). The impacted and control libraries consisted of
5387 and 5275 distinct tags, respectively. The impacted
library had 2615 (33%) distinct transcripts unique to that
particular library, the control library had 2503 (32%) distinct
transcripts unique to that library, and 2772 (35%) of the
distinct transcripts were common to both. Approximately
40% of the 42,530 tags were detected more than once in
either library.
A total of 12 tags were abundantly expressed (each tag
individually accounting for at least 0.5% of the total number
of SAGE tags detected) (Table II). Gene Ontology (http://
www.geneontology.org; GO) annotations were determined
for each gene product represented. GO terms are consis-
tent descriptions of gene products in terms of the biological
processes they are involved in, the cellular components in
which they exist, and the molecular functions they perform.
Using the biological process annotations, these tags repre-
sented highly expressed genes associated with protein bio-
synthesis, iron transport, and regulation of calcium binding.I
ted and control cartilage
GO termdbiological process
Positive regulation of calcium ion concentration, positive regulation
of cell adhesion, positive regulation of IL1 secretion, regulation of
protein secretion, acute-phase response, lymphocyte, macrophage
and neutrophil chemotaxis, negative regulation of inﬂammatory
response, platelet activation
Metabolism
Transport
Fertilization, lipid metabolism, immune response, apoptosis,
cell death, complement-activationdclassical pathway
Protein biosynthesis
TGF-beta receptor complex assembly
Protein biosynthesis
Protein biosynthesis
Protein biosynthesis
Pepsin A activity, peptidase activity, CATHD activity
Iron ion homeostasis, iron ion transport
Calcium ion binding, iron ion transport, collagen binding
Table III
Differentially expressed SAGE tags between impacted and control libraries after 14 days in culture and their gene annotations
Gene identiﬁcation* No. tags in
impacted
No. tags
in control
Fold-
changey
Nominal
P value
P value
FDRz
GO termdbiological process
Proliferation and apoptosis
CAPNS1 91 23 4.04 <1 106 <1 105 Positive regulation of cell proliferation
CAPNS1 0 14 NA 0.000006 0.0028 Positive regulation of cell proliferation
FTH1 50 127 0.40 <1 106 <1 106 Iron ion transport and homeostasis, cell
proliferation, negative regulation of cell
proliferation, immune response, intracellular
sequestering of iron ion
FTH1 0 10 NA 0.000164 0.0350 Iron ion transport and homeostasis, cell
proliferation, negative regulation of cell
proliferation, immune response, intracellular
sequestering of iron ion
FTL 143 168 0.87 0.000074 0.0234 Iron ion transport and homeostasis
MDK precursor 21 2 10.73 0.000125 0.0308 Neurogenesis, regulation of cell cycle, signal
transduction, cell proliferation and
differentiation, response to wounding,
cellecell signaling
RPS27 18 39 0.47 0.000077 0.0234 Protein biosynthesis, signal transduction, cell
proliferation
S100A11dS100C protein 66 90 0.75 0.000137 0.0309 Negative regulation of DNA replication and
cell proliferation
CLU 286 140 2.09 <1 106 <1 105 lipid metabolism, apoptosis, cell death,
immune response, complement-activationd
classic pathway
Metabolism activation and hypoanabolism
COL1A1x 61 12 5.20 <1 106 <1 106 Phosphate transport, skeletal and epidermis
development
COL2A1x 76 120 0.65 <1 106 <1 106 Phosphate transport, cell adhesion, skeletal
development
FMOD 176 295 0.61 <1 106 <1 106 TGF-beta receptor complex assembly
GP38K 544 1291 0.43 <1 106 <1 106 Metabolism
GP38K 9 57 0.16 <1 106 <1 106 Metabolism
GP38K 1 19 0.05 0.000001 0.0005 Metabolism
GP38K 0 12 NA 0.000032 0.0120 Metabolism
NACA 6 24 0.26 0.000033 0.0118 Protein biosynthesis, nascent polypeptide
association
RPL11 58 106 0.56 <1 106 <1 106 Protein biosynthesis
RPL13a 50 74 0.69 0.000117 0.0298 Protein biosynthesis
RPL23 25 45 0.57 0.000202 0.0419 Protein biosynthesis
RPLP2 90 114 0.81 0.000136 0.0316 Protein biosynthesis, translational
elongation
RPS14 20 45 0.45 0.000017 0.0075 Protein biosynthesis
RPS14 19 1 19.42 0.000072 0.0237 Protein biosynthesis
RPS18 124 56 2.26 0.000048 0.0165 Protein biosynthesis
RPS20 61 86 0.73 0.000101 0.0266 Protein biosynthesis
RPS23 0 43 ND <1 106 <1 106 Protein biosynthesis
TMED2 2 14 0.15 0.000236 0.0466 Intracellular protein transport
APOD 46 71 0.66 0.000079 0.0231 Transport, lipid metabolism
COX8A 2 14 0.15 0.000236 0.0454 Electron transport
GAPDH 0 10 NA 0.000164 0.0359 Glucose metabolism, glycolysis
Degradative enzymes
MMP3 1 37 0.03 <1 106 <1 106 Collagen catabolism
CATHBx 65 20 3.32 0.000019 0.0079 Proteolysis and peptidolysis
NGALdlipocalin 2 313 683 0.47 <1 106 <1 106 Transport
CAPNS1 91 23 4.04 <1 106 <1 106 Positive regulation of cell proliferation
CAPNS1 0 14 NA 0.000006 0.0028 Positive regulation of cell proliferation
SERPINA3-1 0 39 NA <1 106 <1 106 Acute-phase response, regulation of lipid
metabolism, inﬂammatory response
SERPINA3-3 0 39 NA <1 106 <1 106 Acute-phase response, regulation of lipid
metabolism, inﬂammatory response
Alterations in chondrocyte phenotype
COL1A1x 61 12 5.20 <1 106 <1 106 Phosphate transport, skeletal and
epidermis development
COL2A1x 76 120 0.65 <1 106 <1 106 Phosphate transport, cell adhesion,
skeletal development
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Table III (continued )
Gene identiﬁcation* No. tags in
impacted
No. tags
in control
Fold-
changey
Nominal
P value
P value
FDRz
GO termdbiological process
CATHBx 65 20 3.32 0.000019 0.0079 Proteolysis and peptidolysis
Other genes
SAA2 1781 1838 0.99 <1 106 <1 106 Positive regulation of calcium ion
concentration, positive regulation of cell
adhesion, positive regulation of IL1 secretion,
regulation of protein secretion, acute-phase
response, lymophycyte, macrophage and
neutrophil chemotaxis, negative regulation of
inﬂammatory response, platelet activation
SAA2 1 15 0.07 0.000025 0.0099 Positive regulation of calcium ion
concentration, positive regulation of cell
adhesion, positive regulation of IL1 secretion,
regulation of protein secretion, acute-phase
response, lymophycyte, macrophage and
neutrophil chemotaxis, negative regulation of
inﬂammatory response, platelet activation
SRPSOX 1 12 0.09 0.000234 0.0473 Receptor-mediated endocytosis, lymphocyte
chemotaxis
Unknowndmatches
multiple porcine genes
134 64 2.14 0.000085 0.0231 Unknown
*Gene identiﬁcation based on 100% match to the NCBI Sus scrofa NlaIII reliable tag-to-gene mappings ﬁle. Tags were also compared to the
pig non-redundant database and the pig SAGE14 database (http://compbio.dfci.harvard.edu/tgi/) using BLAST for gene identiﬁcation
conﬁrmation.
yFold-changes reﬂect normalization of the number of tags identiﬁed in each library. Fold-changes> 1.00 indicate up-regulation in impacted
tissues; fold-changes< 1.00 indicate down-regulation in impacted tissues. Shaded lines represent tags up-regulated in the impacted library.
zFDR-correction for multiple testing.
xCOL1A1 and COL2A1 are included in both the metabolism activation and alterations in chondrocyte phenotype categories. CATHB is
included in both the degradative enzymes and alterations in chondrocyte phenotype categories.
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the impacted and control libraries (Table III). Five transcripts
were represented by more than one tag [calpain I light
subunit (CAPNS1), serum amyloid A2 (SAA2), 38 kDa hep-
arin-binding glycoprotein (GP38K), ferritin heavy chain 1
(FTH1), and 40S ribosomal protein S14 (RPS14)] and one
tag represented two related genes, serine protease inhibitor
(SERPINA) 3-1 and SERPINA 3-3. Of the ﬁve genes repre-
sented by multiple SAGE tags, three agreed and two dis-
agreed in the direction of the changes. For example, the
four tags representing GP38K all indicated that this gene
was down-regulated in the impacted library. The tags repre-
senting CAPSN1 and RPS14 provided conﬂicting results, in
which one tag indicated the gene was up-regulated in the
impacted library and the other tag from the same transcript
indicated down-regulation in the impacted library. For the
CAPNS1 transcript, one tag was sequenced 91 times in
the impacted library and 23 times in the control library while
the second tag was only found in the control library. Com-
parison of these two tags to the pig gene index (http://
compbio.dfci.harvard.edu/tgi/) revealed that the second
tag (down-regulated in the impaction library) only matched
the CAPNS1 sequence for 20 of 21 nucleotides, suggesting
that this tag may not represent the CAPNS1 gene. The ﬁrst
tag (up-regulated in the impaction library) clearly represents
the CAPNS1 gene because it was detected in both libraries
and matched 21 out of 21 nucleotides, providing more
convincing results for this particular gene.
The 39 tags that were differentially expressed in the two
libraries represent 30 different genes. The tags assigned
a single gene identiﬁcation were categorized according to
their gene product’s biological role using GO biological pro-
cess annotations (http://www.geneontology.org; Table III).Many tags represent gene products associated with
matrix molecules, iron and phosphate transport, protein
biosynthesis, skeletal development, cell proliferation, lipid
metabolism and the inﬂammatory response. Twenty-three
of the 30 unique genes were down-regulated in the
impacted library. Only ﬁve unique genes were up-regulated
in the impacted library and included clusterin (CLU),
collagen type I, alpha 1 chain (COL1A1), cathepsin B
(CATHB), midkine (MDK) and 40S ribosomal protein S18
(RPS18). As stated previously, two genes (CAPNS1 and
RPS14) had tags that suggested both up- and down-
regulation in the impacted library.REAL-TIME PCR RESULTSFour genes differentially expressed between SAGE li-
braries were selected for quantitative real-time PCR. These
genes were MMP3, 40S ribosomal protein S23 (RPS23),
FTH1, and GP38K (Table IV). MMP3 was signiﬁcantly
differentially expressed (P¼ 0.002) between tissues, with
a 90.9-fold difference in gene expression. This fold-change
was larger than reported with the SAGE libraries (53.3-fold
difference in gene expression). The remaining three genes
were not signiﬁcantly differentially expressed, but FTH1
(P¼ 0.071) and GP38K (P¼ 0.136) were approaching
signiﬁcance. FTH1 and GP38K were down-regulated
9.43- and 8.26-folds, respectively. Fold-changes estimated
by real-time PCR for FTH1 and GP38K were greater than
fold-changes estimated by SAGE (3.18 and 3.14, respec-
tively). RPS23 was down-regulated 1.89-fold using real-
time PCR, however, a fold-change could not be estimated
for this gene using the SAGE data because no RPS23
tags were sequenced in the impacted library.
Table IV
Differential expression of GP38K, FTH1, MMP3, and RPS23 between impacted and control cartilage tissues
Gene Fold-change* 95% CI for real-time
RT-PCR fold-change*,y
P valuey
SAGE Real-time PCRy
GP38K 0.318 0.121 0.02e1.06 0.136
FTH1 0.314 0.106 0.02e0.81 0.071
MMP3 0.019 0.011 0.003e0.04 0.002
RPS23z NA 0.529 0.09e3.70 0.726
*Fold-changes> 1.00 represent up-regulation in impacted tissues; fold-changes< 1.00 represent down-regulation in impacted tissues.
yEstimated with REST v1.9.1242,43.
zFold-change could not be accurately estimated from SAGE libraries because no tags matching RPS23 were found in the impacted library.
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Cartilage tissue degeneration is an important but poorly
understood phenomenon in several human diseases, in-
cluding OA. OA is the most common type of arthritis and
is expected to rise due to increased incidence of obesity
and age of the population1. Studies aimed at understanding
degenerative joint disease using a functional genomics
approach have grown since the early 2000s27,29,32,44e47.
These studies have cataloged the genes expressed in
chondrocytes as well as documented those that are
differentially expressed in normal and diseased states. In
this study we have used SAGE34 to document changes in
global transcript proﬁles of axially impacted and non-
impacted control chondrocytes using our porcine impact
injury model in an attempt to document the early changes
in gene expression after an induced injury. SAGE is an
unbiased method in which the relative gene expression
levels of known and unknown genes can be assessed. At
this time, draft sequencing of the pig genome has begun,
but will require more time before it can be completed and
fully annotated. SAGE was selected over microarrays
because most pig transcript libraries have been constructed
from agriculturally relevant tissues, of which cartilage is not
one. Therefore, an open platform such as SAGE was
selected over a closed microarray platform to prevent
potential omission of genes important in cartilage biology.
An in vitro model was used that consisted of a single im-
paction with a stainless steel impactor making direct contact
with the articular surface of a patella that had been excised
from the joint. Though this is an in vitro model, using intact
patellae preserves the normal bone and cartilage boundary
conditions during the impaction. The patellae are cultured
intact to keep the cartilage in as natural an environment
as possible and to eliminate any collateral damage that
could result from removal of the cartilage from the underly-
ing bone and surrounding cartilage. In this study only one
time point was examined, 14 days post-impaction. This
time point was selected to examine relatively early changes
in gene expression in this impact injury model. While
cartilage impact injuries have often been used as surro-
gates for the study of OA, our in vitro model has never
been taken out to determine if the degeneration resulting
from our impactions would continue on to full blown OA
and no similar studies have been carried out in vivo in the
pig to see how or if this model would progress. Nonetheless
impact models in dogs12,17 and rabbits11,13e16 have been
shown to develop osteoarthritic like changes.
Transcripts corresponding to 12 genes (Table II)
are abundant in pig chondrocytes, all of which have
been previously reported to be found in cartilage tis-
sue3,44e46,48e50,52,53. Four of the abundant tags correspond
to gene products involved in protein biosynthesis,contributing to the large and small ribosomal subunits. Six
of these 12 abundantly expressed tags are differentially ex-
pressed in the control and impacted tissue after 14 days in
organ culture and are discussed in more detail below.
We identiﬁed 39 differentially expressed SAGE tags in
our two libraries. These 39 tags represent 30 annotated
genes, many of which have previously been implicated in
OA or rheumatoid arthritis. The reaction patterns of osteoar-
thritic chondrocytes have been divided into ﬁve categories:
cell proliferation and apoptosis, metabolic activation and
hypoanabolism, degradative enzymes, alterations of the
chondrocytic phenotype, and osteophyte formation54.
Based on GO annotations for the 30 differentially expressed
genes, we observed changes in four of the ﬁve categories
which are discussed in detail below. None of the genes
differentially expressed in our model fell into the osteophyte
formation category.PROLIFERATION AND APOPTOSISMany studies have shown cell proliferation in osteoarthritic
chondrocytes30 and indicated that this proliferation may be
responsible for chondrocyte clustering30 or cloning. In pre-
liminary histological studies using this impact injury model,
we, too, have seen indirect evidence of cell proliferation35,36.
Of the 30 differentially expressed genes we identiﬁed in the
SAGE libraries, six were classiﬁed as being involved in cell
proliferation (Table III). These genes include CAPNS1,
FTH1, ferritin light subunit (FTL), MDK, 40S ribosomal pro-
tein S27 (RPS27) and calgizzarin (S100A11). The subunits
of ferritin (FTH1 and FTL), as well as S100A11, which are
involved in iron and calcium binding, respectively, are
down-regulated in our impacted library and are known to
negatively regulate cell proliferation (http://www.geneonto
logy.org). Therefore early down-regulation of these genes
supports ﬁndings of cell proliferation within damaged carti-
lage. Telfer and Brock49 studied the expression of FTH1
and FTL, respectively, in human rheumatoid synovium.
FTH1 is responsible for iron detoxiﬁcation, so down-
regulation of this gene may lead to a build up of iron at toxic
levels, contributing to tissue damage, even when cells are in
a proliferative state.
CAPNS1 and MDK, affecting cytoskeletal remodeling and
growth promoting activities, respectively, are associated
with positive regulation of proliferation (http://www.geneon
tology.org). Therefore up-regulation of these particular
genes may also indicate proliferation of the chondrocytes
in the cartilage.
Of the 30 differentially expressed genes in our study, only
CLU was associated with apoptosis and was up-regulated
in the impacted SAGE library. This result also agrees with
many other studies, in which an increase in CLU gene
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degenerating tissues32,46. Involvement of apoptosis in the
degenerative process is controversial; some groups have
identiﬁed apoptotic cells in OA samples21,55 while others
have argued that, due to technical issues, the levels of
apoptosis in OA samples have been overestimated56.
Recent histological data with our model indicate that the
timing of apoptosis is dependent on the level of impaction,
with smaller impactions showing increased apoptosis
earlier than larger impactions, possibly due to an increase
in outright necrosis seen at early time points for larger
impactions (unpublished results).METABOLIC ACTIVATION AND HYPOANABOLISMMany studies comparing osteoarthritic and normal
tissues have shown increased synthesis of components
making up the extracellular matrix. We identiﬁed four genes
producing components of the extracellular matrix that were
differentially expressed in our experiment. These genes
were ﬁbromodulin (FMOD), COL1A1, collagen type II, alpha
1 (COL2A1) and GP38K, each of which we found to be
down-regulated with the exception of COL1A1. FMOD is
a small leucine-rich proteoglycan believed to interact with
type I and type II collagen ﬁbrils57 and regulate transforming
growth factor-beta’s action44. Since FMOD can form a com-
plex with this growth factor, down-regulation of FMOD may
have signiﬁcant effects on chondrocyte metabolism44.
Down-regulation of COL2A1 may indicate reduced gene
products, preventing the cells from producing the necessary
collagen needed to mount a repair. GP38K, also known as
chitinase-3-like protein 1 precursor, may play an important
role in helping cells cope and respond to changes in their
environment, potentially promoting tissue remodeling58.
With a reduction in its transcript, the chondrocytes may
not be able to repair themselves, eventually leading to joint
degeneration.
Ten genes associated with protein biosynthesis were dif-
ferentially expressed in our experiment, including nine ribo-
somal proteins. Nine of the 10 genes were down-regulated
in the impacted library, suggesting these cells may lose
their ability to produce the proteins needed for repair or
maintenance. NACA, the gene coding for the nascent
polypeptide-associated complex, was also down-regulated.
This gene product binds to newly formed polypeptides as
they emerge from the ribosome and blocks their interaction
with the signal recognition particle, preventing non-
secretory polypeptides from being inappropriately targeted
to the endoplasmic reticulum59. This gene product has
also been reported to be translocated to the nucleus where
it is a transcriptional coactivator that is selectively ex-
pressed in developing bone tissue during embryogenesis60.
The transmembrane emp24 domain trafﬁcking protein 2
(TMED2) gene product has a similar function in which it
mediates intracellular trafﬁcking of polypeptides between
the endoplasmic reticulum and Golgi apparatus61. Perhaps
down-regulation of the TMED2 and NACA genes leads to
inappropriate processing of newly synthesized polypeptides
in damaged chondrocytes. One might speculate that the
chondrocytes may be able to produce the gene products
needed to repair damage but lose the machinery to process
those products appropriately, producing an altered or
inferior repair molecule.
Genes classiﬁed as being differentially expressed and
involved in metabolism were apolipoprotein D (APOD),
cytochrome c oxidase subunit 8A (COX8A) andglyceraldehyde-3-phosphate dehydrogenase (GAPDH), all
of which were down-regulated following impaction in our ex-
periment. The GAPDH result may be a false positive be-
cause only one of nine unique tags associated with this
gene was differentially expressed in our two SAGE libraries.
Indeed, quantitative real-time PCR results indicate that
GAPDH was not differentially expressed in these tissues
when a second housekeeping gene (ACTB) was used (re-
sults not shown).
APOD is a component of high density lipoproteins and is
known to closely associate with lecithin:cholesterol acyl-
transferase62. Expression of APOD was recently reported
in the developing antler of red deer where its expression
was inversely related to cell proliferation63. Down-regulation
of this gene in our impacted tissue may therefore indicate
a proliferative state in the damaged tissue.
COX8A is a gene whose product contributes a subunit to
the cytochrome c oxidase complex, the last enzyme of the
respiratory chain producing the proton gradient across the
inner mitochondrial membrane. Since this gene was
down-regulated in our impacted tissue, it is possible that
the mitochondria in these cells are less active, producing
less ATP. This ﬁnding is supported by Blanco et al.64,
who found that OA chondrocytes had decreased mitochon-
drial respiratory chain activity. They reported that while the
total mitochondrial mass increased in OA tissue, the
chondrocytes in these tissues had reduced mitochondrial
membrane potentials64. Since chondrocyte matrix synthesis
is modulated by the balance between ATP consumption
and production, the chondrocytes in our impacted tissues
may not have enough energy to perform repairs, contribut-
ing to degeneration.DEGRADATIVE ENZYMESChondrocytes are known to produce many degradative
enzymes, including metalloproteinases and serine and cys-
teine proteinases. In our experiment, we found that
transcript levels of MMP3 were reduced in the impacted
tissue. In some OA studies, protein levels of MMPs and
other proteinases are increased32,33 while in other studies
the MMP3 gene was found to be down-regulated31,45,65.
Aigner et al.65 found that the MMP3 gene was down-
regulated by approximately 3.5-fold in cartilage lesions
with moderate and severe OA when compared with normal
tissue samples. We found that MMP3 was down-regulated
by 53.3-fold (Table IV; fold-change¼ 0.019) in our SAGE
libraries and 90.9-fold (Table IV: fold-change¼ 0.011) using
quantitative real-time PCR. Since the amount of transcript
does not always reﬂect the amount of gene product pro-
duced, Monfort et al.66 examined both mRNA and protein
levels of MMP3 in articular cartilage collected from healthy
and OA human hips. They found that MMP3 mRNA and
protein levels were decreased in healthy tissue when load
was applied to the cartilage but no differences were
detected in OA samples. Further evaluation of MMP3
protein levels is currently underway using our model and
may shed light onto the differences in MMP3 results across
studies.
Based on SAGE, transcript levels of two proteases,
CATHB and CAPNS1, were up-regulated after 14 days in
organ culture in impacted tissue compared to control.
CATHB is a cysteine proteinase thought to participate in
intracellular protein degradation and turnover67, which is
indicative of the degradation seen in OA. Previous studies
have found that higher levels of this enzyme exist in human
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highest enzyme activity can be found in proliferating
chondrocytes28, again suggesting that chondrocytes may
attempt to repair damaged tissue through cell proliferation.
CAPNS1 is a calcium-dependent cysteine protease that
can be activated by an inﬂux of calcium and catalyzes
proteolysis of substrates involved in cytoskeletal remodel-
ing68. It has also been associated with positive regulation
of cell proliferation (Table III), contributing further evidence
that the chondrocytes in the impacted tissues are proliferat-
ing. Up-regulation of CATHB and CAPNS1 may indicate
that these gene products may be more important in the
degenerative pathway than MMP3 at this particular point
in the process.
While not deﬁned as a proteinase, the gene product of
neutrophil gelatinase-associated lipocalin (NGAL) has
been reported to form a heterodimer with matrix metallo-
proteinase 9 (MMP9), protecting this collagenase from
auto-degradation50. Therefore, down-regulation of the
NGAL transcript suggests that MMP9 may undergo
degradation and may not be available to degrade other
proteins within the damaged tissue. This result may indi-
cate an attempt by the chondrocytes to prevent further
proteolysis.
In addition to the reported increase in the amount of
degradative enzymes produced by damaged chondro-
cytes32,33, the expression levels of many proteinase
inhibitors are changed in OA. Many studies have shown
that the expression levels of tissue inhibitors of MMPs
(TIMPs) are altered33,45,69. Although tags representing
TIMP1 and TIMP2 were identiﬁed in our SAGE libraries,
they were not signiﬁcantly differentially expressed. SER-
PINA3 is the only protease inhibitor we found to be differen-
tially expressed in our experiment. It was down-regulated in
the impacted SAGE library, indicating that reduced levels of
this gene product may contribute to matrix degeneration.ALTERATIONS IN CHONDROCYTE PHENOTYPEMany studies have suggested that chondrocytes may de-
differentiate to a ﬁbroblast-like phenotype in osteoarthritic
cartilage27,28. These de-differentiated cells do not express
aggrecan or type II collagen, but instead revert to a more
fetal-like phenotype, producing collagen types I, III and
V54. We found an up-regulation of type I collagen and
a down-regulation of type II collagen, supporting the de-
differentiation hypothesis. We also observed tags corre-
sponding to other collagens, including those representing
collagens III, V and IX, but none were signiﬁcantly differen-
tially expressed in our two libraries. Previous studies have
found that CATHB, found to be up-regulated in our
impacted library, is a marker for de-differentiated chondro-
cytes28, providing further evidence of the chondrocyte de-
differentiation phenotype in damaged cells.THE REMAINING GENESThere is a long way to go before the role of many of the
genes involved in the degenerative process are understood
and the function that many genes play in the process
cannot always be easily deduced. Two genes that have
shown signiﬁcantly different expression in the two libraries
do not easily ﬁt into one of the categories deﬁned by
Sandell and Aigner54. Scavenger receptor for phosphatidyl-
serine and oxidized low density lipoprotein (SRPSOX) and
SAA2 are both genes that have previously been associatedwith rheumatoid arthritis51,70, are involved in the inﬂamma-
tory response, and may be associated with lipid homeosta-
sis in chondrocytes51. SAA2 is an acute-phase response
protein and is usually present at sites of tissue damage,
becoming the major apolipoprotein of the high density lipo-
protein complex. Recent reports indicate that this protein
may help remove excess cholesterol from macrophages
present in damaged tissue71. While statistically signiﬁcant,
biological relevance of SAA2 in our model is unknown given
the fact that the differential expression between the two
libraries was 0.99-fold. Previous studies of SRPSOX, also
known as chemokine C-X-C motif ligand 16 (CXCL16),
have predominantly involved the study of atherosclerosis
and have recently been associated with lower clinical
rheumatoid arthritis scores70. Down-regulation of SAA2
and SRPSOX, as observed in our experiment, suggests
the possibility of impaired cholesterol efﬂux in the damaged
chondrocytes.
In this experiment, we have evaluated the mRNA
transcripts present in axially impacted porcine articular
chondrocytes maintained in organ culture for 14 days using
SAGE and validated four using quantitative real-time PCR.
Only one of four genes validated by real-time PCR was
statistically signiﬁcant at P< 0.05. Signiﬁcant variation in
real-time PCR CT values within treatment group, especially
for controls, was observed. This variation likely contributed
to our inability to ﬁnd a statistically signiﬁcant result for the
remaining three genes. Selecting speciﬁc breeds or lines
of pigs may decrease variance in CT values among samples
in future studies. Regardless, two of three statistically
non-signiﬁcant genes were approaching signiﬁcance (P<
0.14). Because these genes were signiﬁcantly differentially
expressed between SAGE libraries and were approaching
signiﬁcance, changing in the same direction as was found
with SAGE, we believe our real-time PCR results
compliment our SAGE results.
Results using our porcine injury model of OA have
contributed further evidence that damaged chondrocytes
may de-differentiate into ﬁbroblast-like cells and proliferate
in an attempt to repair themselves, supported by the up-
regulation of six genes in our experiment. The remaining
24 differentially expressed genes were down-regulated in
the impacted tissue, in some cases producing results that
conﬂict with others’ ﬁndings. However, evaluation of tran-
script levels is just one piece of the puzzle and evaluation
of their gene products is currently underway.
Degeneration is a very complex process, varying in time
and location within the tissue. We have examined a single
time point with tissue maintained in culture 14 days post-
impaction using full thickness sections of tissue directly
below an induced impact injury and compared it to non-
impacted tissue also maintained for 14 days in culture. A
more detailed examination of the spatial distribution and
the timing of the observed genomic changes are neces-
sary to get an accurate picture of the pathways leading
to cartilage degeneration. One of the objectives of the
SAGE library experiment was to generate a list of genes
and gene products we wish to study in further detail.
Examining other time points is necessary in order to estab-
lish a more deﬁned chronology for the steps leading to
cartilage degeneration and to outline potential points of in-
tervention. Transcript levels of selected genes will also
need to be evaluated to elucidate the initial gene expres-
sion changes in these damaged chondrocytes, with the in-
tent of providing us with a more complete story about the
fate of the chondrocytes in articular cartilage following an
injury.
945Osteoarthritis and Cartilage Vol. 16, No. 8Conﬂict of interest
The authors declare no conﬂicts of interest that have any
bearing on this manuscript.Acknowledgments
The authors wish to acknowledge Neese Sausage for pro-
viding the porcine patellae used in this project and Zimmer
for providing the PMMA used. This work was supported in
part by a Faculty Research and Professional Development
grant and the North Carolina Agricultural Experiment
Station.References
1. Arthritis Foundation. National arthritis action plan: a public health
strategy. 1999.
2. Hootman JM, Helmick CG. Projections of US prevalence of arthritis and
associated activity limitations. Arthritis Rheum 2006;54:226e9.
3. Buckwalter A. Osteoarthritis and articular cartilage use, disuse, and
abuse: experimental studies. J Rheumatol Suppl 1995;43:13e5.
4. Buckwalter JA, Mankin HJ. Articular cartilage: degeneration and
osteoarthritis, repair, regeneration, and transplantation. Instr Course
Lect 1998;47:487e504.
5. Howell DS, Treadwell BV, Trippel SV. Etiopathogenesis of osteoarthritis.
In: Moskwitz RW, Howell DS, Goldberg VM, Mankin HJ, Eds. Osteo-
arthritis: Diagnosis and Medical/Surgical Management. Philadelphia,
PA: W. B. Saunders 1992:233e52.
6. Mankin HJ. The response of articular cartilage to mechanical injury.
J Bone Joint Surg 1982;64:460e6.
7. Borrelli J, Ricci WM. Acute effects of cartilage impact. Clin Orthop Relat
Res 2004;423:33e9.
8. Brocklehurst R, Bayliss MT, Maroudas A, Coysh HL, Freeman MA,
Revell PA, et al. The composition of normal and osteoarthritic articular
cartilage from human knee joints. With special reference to
unicompartmental replacement and osteotomy of the knee. J Bone
Joint Surg 1984;66:95e106.
9. Kraus VB. Pathogenesis and treatment of osteoarthritis. Med Clin North
Am 1997;81:85e112.
10. Meachim G, Brooke G. The pathology of osteoarthritis. In:
Moskwitz RW, Howell DS, Goldberg VM, Mankin HJ, Eds. Osteoar-
thritis: Diagnosis and Medical/Surgical Management. Philadelphia,
PA: W. B. Saunders; 1992:29e42.
11. Dekel S, Weissman SL. Joint changes after overuse and peak overload-
ing of rabbit knees in vivo. Acta Orthop Scand 1978;19:519e28.
12. Donohue M, Buss D, Oegema TR Jr, Thompson RC Jr. The effects of
indirect blunt trauma on adult canine articular cartilage. J Bone Joint
Surg 1983;65:948e57.
13. Haut RC, Ide TM, DeCamp CE. Mechanical responses of the rabbit
patello-femoral joint to blunt impact. J Biomech Eng 1995;117:402e8.
14. Newberry WN, Mackenzie CD, Haut RC. Blunt impact causes changes
in bone and cartilage in a regularly exercised animal model. J Orthop
Res 1998;16:348e54.
15. Radin EL, Martin RB, Burr DB, Caterson B, Boyd RD, Goodwin C.
Effects of mechanical loading on the tissues of the rabbit knee.
J Orthop Res 1984;2:221e34.
16. Serink MT, Nachemson A, Hansson G. The effect of impact loading on
rabbit knee joints. Acta Orthop Scand 1977;48:250e62.
17. Thompson RC Jr, Oegema TR Jr, Lewis JL, Wallace L. Osteoarthrotic
changes after acute transarticular load: an animal model. J Bone Joint
Surg 1991;73:990e1001.
18. Wilson W, van Burken C, van Donkelaar C, Buma P, van Rietbergen B,
Huiskes R. Causes of mechanically induced collagen damage in
articular cartilage. J Orthop Res 2006;24:220e8.
19. Clements KM, Bee ZC, Crossingham GV, Adams MA, Sharif M. How
severe must repetitive loading be to kill chondrocytes in articular
cartilage? Osteoarthritis Cartilage 2001;9:499e507.
20. Ewers BJ, Dvoracek-Driksna D, Orth MW, Haut RC. The extent of matrix
damage and chondrocyte death in mechanically traumatized articular
cartilage explants depends on rate of loading. J Orthop Res 2001;19:
779e84.
21. Hashimoto S, Ochs RL, Komiya S, Lotz M. Linkage of chondrocyte
apoptosis and cartilage degradation in human osteoarthritis. Arthritis
Rheum 1998;41:1632e8.
22. Loening AM, Levenston ME, James IE, Nuttall ME, Hung HK, Gowen M,
et al. Injurious compression of bovine articular cartilage induces
chondrocyte apoptosis before detectable mechanical damage.Transactions of the 45th Annual Meeting of the Orthopaedic Research
Society 1999;24:42.
23. Lotz M, Hashimoto S, Kuhn K. Mechanisms of chondrocyte apoptosis.
Osteoarthritis Cartilage 1999;7:389e91.
24. Tew SR, Kwan AP, Hann A, Thomson BM, Archer CW. The reactions of
articular cartilage to experimental wounding: role of apoptosis.
Arthritis Rheum 2000;43:215e25.
25. Kouri JB, Arguello C, Quintero M, Chico A, Ramos ME. Variability in the
cell phenotype of aggregates or ‘‘clones’’ of human osteoarthritic
cartilage. A case report. Biocell 1996;20:191e200.
26. Munoz-Guerra MF, Delgado-Baeza E, Sanchez-Hernandez JJ, Garcia-
Ruiz JP. Chondrocyte cloning in aging and osteoarthritis of the hip
cartilage: morphometric analysis in transgenic mice expressing bo-
vine growth hormone. Acta Orthopaedica Scandinavica 2004;75:
210e6.
27. Aigner T, Dudhia J. Genomics of osteoarthritis. Curr Opin Rheumatol
2003;15:634e40.
28. Zwicky R, Baici A. Cytoskeletal architecture and cathepsin B trafﬁcking
in human articular chondrocytes. Histochem Cell Biol 2000;114:
363e72.
29. Marshall KW, Zhang H, Nossova N. Chondrocyte genomics:
implications for disease modiﬁcation in osteoarthritis. Drug Discov
Today 2006;11:825e32.
30. Aigner T, Zien A, Gehrsitz A, Gebhard PM, McKenna L. Anabolic and
catabolic gene expression pattern analysis in normal versus
osteoarthritic cartilage using complementary DNA-array technology.
Arthritis Rheum 2001;44:2777e89.
31. Yagi R, McBurney D, Laverty D, Weiner S, Horton WE Jr. Intrajoint com-
parisons of gene expression patterns in human osteoarthritis suggest
a change in chondrocyte phenotype. J Orthop Res 2005;23:1128e38.
32. Meng J, Ma X, Ma D, Xu C. Microarray analysis of differential gene
expression in temporomandibular joint condylar cartilage after
experimentally induced osteoarthritis. Osteoarthritis Cartilage 2005;
13:1115e25.
33. Lee JH, Fitzgerald JB, Dimicco MA, Grodzinsky AJ. Mechanical injury of
cartilage explants causes speciﬁc time-dependent changes in
chondrocyte gene expression. Arthritis Rheum 2005;52:2386e95.
34. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW. Serial analysis of
gene expression. Science 1995;270:484e7.
35. Mente PL, Lossing JA, Dinola NE, Chandler EM. Chondrocyte necrosis
and proliferation in mechanically impacted articular cartilage.
Transactions of the 51st Annual Meeting of the Orthopaedic Research
Society 2005;30 (abstract #1035).
36. Mente PL, Chandler EM. Chondrocyte death and cloning in mechani-
cally impacted articular cartilage. BMES Annual Fall Meeting 2005;
786.
37. Audic S, Claverie JM. The signiﬁcance of digital gene expression
proﬁles. Genome Res 1997;7:986e95.
38. Romualdi C, Bortoluzzi S, D’Alessi F, Danieli GA. IDEG6: a web tool for
detection of differentially expressed genes in multiple tag sampling
experiments. Physiol Genomics 2003;12:159e62.
39. Romualdi C, Bortoluzzi S, Danieli GA. Detecting differentially expressed
genes in multiple tag sampling experiments: comparative evaluation
of statistical tests. Hum Mol Genet 2001;10:2133e41.
40. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical
and powerful approach to multiple testing. J Roy Stat Soc 1995;57:
289e300.
41. Pattyn F, Robbrecht P, Speleman F, De Paepe A, Vandesompele J.
RTPrimerDB: the real-time PCR primer and probe database, major
update. Nucleic Acids Res 2006;34:D684e8.
42. Pfafﬂ MW. A new mathematical model for relative quantiﬁcation in real-
time RT-PCR. Nucleic Acids Res 2001;29:e45.
43. Pfafﬂ MW, Horgan GW, Dempﬂe L. Relative expression software tool
(RESTª) for group-wise comparison and statistical analysis of
relative expression results in real-time PCR. Nucleic Acids Res
2002;30:e36.
44. Young AA, Smith MM, Smith SM, Cake MA, Ghosh P, Read RA, et al.
Regional assessment of articular cartilage gene expression and small
proteoglycan metabolism in an animal model of osteoarthritis. Arthritis
Res Ther 2005;7:R852e61.
45. Aigner T, Fundel K, Saas J, Gebhard PM, Haag J, Weiss T, et al. Large-
scale gene expression proﬁling reveals major pathogenetic pathways
of cartilage degeneration in osteoarthritis. Arthritis Rheum 2006;54:
3533e44.
46. Khan IM, Salter DM, Bayliss MT, Thomson BM, Archer CW. Expression
of clusterin in the superﬁcial zone of bovine articular cartilage. Arthritis
Rheum 2001;44:1795e9.
47. Eleswarapu SV, Lepzig ND, Athanasiou KA. Gene expression of single
articular chondrocytes. Cell Tissue Res 2007;327:43e54.
48. Connor JR, Dodds RA, Emery JG, Kirkpatrick RB, Rosenberg M,
Gowen M. Human cartilage glycoprotein 39 (HC gp-39) mRNA
expression in adult and fetal chondrocytes, osteoblasts and osteocyts
by in-situ hybridization. Osteoarthritis Cartilage 2000;8:87e95.
946 M. S. Ashwell et al.: Pig chondrocyte transcript proﬁling49. Telfer JF, Brock JH. Expression of ferritin, transferring receptor, and
non-speciﬁc resistance associated macrophage proteins 1 and 2
(Nramp1 and Nramp2) in the human rheumatoid synovium. Ann
Rheum Dis 2002;61:741e4.
50. Yan L, Borregaard N, Kjeldsen L, Moses MA. The high molecular weight
urinary matrix metalloproteinase (MMP) activity is a complex of
gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin
(NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem 2001;
276:37258e65.
51. Zerega B, Pagano A, Pianezzi A, Ulivi V, Camardella L, Cancedda R,
et al. Expression of serum amyloid A in chondrocytes and myoblasts
differentiation and inﬂammation: possible role in cholesterol
homeostasis. Matrix Biol 2004;23:35e46.
52. Ruiz-Romero C, Lopez-Armada MJ, Blanco FJ. Proteomic characteriza-
tion of human normal articular chondrocytes: a novel tool for the study
of osteoarthritis and other rheumatic diseases. Proteomics 2005;5:
3048e59.
53. Wahl M, Shukunami C, Heinzmann U, Hamajima K, Hiraki Y, Imai K.
Transcriptome analysis of early chondrogenesis in ATDC5 cells
induced by bone morphogenetic protein 4. Genomics 2004;83:
45e58.
54. Sandell LJ, Aigner T. Articular cartilage and changes in arthritis. An
introduction: cell biology of osteoarthritis. Arthritis Res 2001;3:
107e13.
55. Blanco FJ, Guitian R, Vazquez-Martul E, de Toro FJ, Galdo F.
Osteoarthritis chondrocytes die by apoptosis. A possible pathway
for osteoarthritis pathology. Arthritis Rheum 1998;41:284e9.
56. Aigner T, Hemmel M, Neureiter D, Gebhard PM, Zeiler G, Kirchner T,
et al. Apoptotic cell death is not a widespread phenomenon in normal
aging and osteoarthritis human articular knee cartilage: a study of
proliferation, programmed cell death (apoptosis), and viability of
chondrocytes in normal and osteoarthritic human knee cartilage.
Arthritis Rheum 2001;44:1304e12.
57. Chakravarti S. Functions of lumican and ﬁbromodulin: lessons from
knockout mice. Glycoconj J 2003;19:287e93.
58. Recklies AD, Ling H, White C, Bernier SM. Inﬂammatory cytokines
induce production of CHI3L1 by articular chondrocytes. J Biol Chem
2005;280:41213e21.59. Wiedmann B, Sakai H, Davis TA, Wiedmann M. A protein complex
required for signal-sequence-speciﬁc sorting and translocation.
Nature 1994;370:434e40.
60. Moreau A, Yotov WV, Glorieux FH, St-Arnaud R. Bone-speciﬁc
expression of the alpha chain of the nascent polypeptide-associated
complex, a coactivator potentiating c-Jun-mediated transcription.
Mol Cell Biol 1998;18:1312e21.
61. Carney GE, Bowen NJ. P24 proteins, intracellular trafﬁcking, and behav-
ior: Drosophila melanogaster provides insights and opportunities. Biol
Cell 2004;96:271e8.
62. Rassart E, Bedirian A, Do Carmo S, Guinard O, Sirois J, Terrisse L,
et al. Apolipoprotein D. Biochim Biophys Acta 2000;1482:185e98.
63. Molnar A, Gyurjan I, Korpos E, Brsy A, Steger V, Buzas Z, et al.
Identiﬁcation of differentially expressed genes in the developing antler
of red deer Cervus elaphus. Mol Genet Genomics 2007;277:237e48.
64. Blanco FJ, Lopez-Armada MJ, Maneiro E. Mitochondrial dysfunction in
osteoarthritis. Mitochondrion 2004;4:715e28.
65. Aigner T, Zien A, Hanisch D, Zimmer R. Gene expression in
chondrocytes assessed with use of microarrays. J Bone Joint Surg
2003;85:117e23.
66. Monfort J, Garcia-Giralt N, Lopez-Armada MJ, Monllau JC, Bonilla A,
Benito P, et al. Decreased metalloproteinase production as a response
to mechanical pressure in human cartilage: a mechanism for
homeostatic regulation. Arthritis Res Ther 2006;8:R149.
67. Zwicky R, Muntener K, Goldring MB, Baici A. Cathepsin B expression
and down-regulation by gene silencing and antisense DNA in human
chondrocytes. Biochem J 2002;367:209e17.
68. Lebart M-C, Benyamin Y. Calpain involvement in the remodeling
of cytoskeletal anchorage complexes. FEBS J 2006;273:3415e26.
69. Clements DN, Carter SD, Innes JF, Ollier WER, Day P. Analysis of
normal and osteoarthritic canine cartilage mRNA expression by quan-
titative polymerase chain reaction. Arthritis Res Ther 2006;8:R158.
70. Nanki T, Shimaoka T, Hayashida K, Taniguchi K, Yonehara S,
Miyasaka N. Pathogenic role of the CXCL16eCXCR6 pathway in
rheumatoid arthritis. Arthritis Rheum 2005;52:3004e14.
71. Van der Westhuyzen DR, Cai L, de Beer MC, de Beer FC. Serum
amyloid A promotes cholesterol efﬂux mediated by scavenger
vvreceptor B-I. J Biol Chem 2005;280:35890e5.
